Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Integrated TCR repertoire analysis and single-cell transcriptomic profiling of tumor-infiltrating T cells in renal cell carcinoma identifies shared and tumor-restricted expanded clones with unique phenotypes. | Front Oncol | 2022 | 36185254 | PubTator, text mining | PubMed |
| GRAP2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma. | J Clin Lab Anal | 2022 | 36181310 | PubTator, text mining | PubMed |
| PLK4 Is a Potential Biomarker for Abnormal Tumor Proliferation, Immune Infiltration, and Prognosis in ccRCC. | Comput Math Methods Med | 2022 | 36176741 | PubTator, text mining | PubMed |
| How sphingolipids affect T cells in the resolution of inflammation. | Front Pharmacol | 2022 | 36176439 | PubTator, text mining | PubMed |
| Nanoengineering facilitating the target mission: targeted extracellular vesicles delivery systems design. | J Nanobiotechnology | 2022 | 36175866 | PubTator, text mining | PubMed |
| Comprehensive analysis about prognostic and immunological role of WTAP in pan-cancer. | Front Genet | 2022 | 36171885 | PubTator, text mining | PubMed |
| Pan-cancer analysis of a novel indicator of necroptosis with its application in human cancer. | Aging (Albany NY) | 2022 | 36170029 | PubTator, text mining | PubMed |
| Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy. | Theranostics | 2022 | 36168626 | PubTator, text mining | PubMed |
| CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study. | Hereditas | 2022 | 36167571 | PubTator, text mining | PubMed |
| FOXP family DNA methylation correlates with immune infiltration and prognostic value in NSCLC. | Front Genet | 2022 | 36160018 | PubTator, text mining | PubMed |
| Immune status for monitoring and treatment of bladder cancer. | Front Immunol | 2022 | 36159866 | PubTator, text mining | PubMed |
| Non-coding RNA-mediated high expression of SFXN3 as a prognostic biomarker associated with paclitaxel resistance and immunosuppressive microenvironment in head and neck cancer. | Front Immunol | 2022 | 36159813 | PubTator, text mining | PubMed |
| A comprehensive role evaluation and mechanism exploration of POGLUT2 in pan-cancer. | Front Oncol | 2022 | 36158688 | PubTator, text mining | PubMed |
| High Expression of EIF4G2 Mediated by the TUG1/Hsa-miR-26a-5p Axis Is Associated with Poor Prognosis and Immune Infiltration of Gastric Cancer. | J Oncol | 2022 | 36157241 | PubTator, text mining | PubMed |
| The immune subtypes and landscape of sarcomas. | BMC Immunol | 2022 | 36153483 | PubTator, text mining | PubMed |
| Comprehensive Characterization of Immune Landscape Based on Tumor Microenvironment for Oral Squamous Cell Carcinoma Prognosis. | Vaccines (Basel) | 2022 | 36146599 | PubTator, text mining | PubMed |
| Identification of a Gene Panel Predictive of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy Employing Transcriptomic and Functional Validation. | Int J Mol Sci | 2022 | 36142814 | PubTator, text mining | PubMed |
| Functional Interactions of Kluyveromyces lactis Telomerase Reverse Transcriptase with the Three-Way Junction and the Template Domains of Telomerase RNA. | Int J Mol Sci | 2022 | 36142669 | PubTator, text mining | PubMed |
| The Urinary Microbiome: Role in Bladder Cancer and Treatment. | Diagnostics (Basel) | 2022 | 36140470 | PubTator, text mining | PubMed |
| Transwell migration assay to interrogate human CAR-T cell chemotaxis. | STAR Protoc | 2022 | 36136753 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=27